The NHS makes mistakes but we are privileged to have access to what is, more often than not, excellent quality care.
Not everyone in the world is as lucky. This vaccine, if approved, could make a huge difference to children in the most remote areas.
Hopes are growing for a new, inexpensive, heat-proof vaccine to protect against a disease which kills 1,300 children a day following a successful trial in Niger. The vaccine was found to be almost 67% effective in preventing gastroenteritis caused by rotavirus, the most common cause of severe diarrheal disease in the world. The two existing vaccines require refrigeration and can be costly. The new drug would be half the price. More than 500,000 children die each year from dehydration and complications of rotavirus, particularly in sub-Saharan Africa, according to the World Health Organization. But the current vaccines are difficult to transport and administer as they must be refrigerated at all times. A vaccine which does not need to be refrigerated would be able to reach children in even the most remote areas.